296 studies found for:    NIAMS "National Institute of Arthritis and Musculoskeletal and Skin Diseases"
Show Display Options
Rank Status Study
1 Recruiting Blood Component Collection From Patients With Rheumatic Disease and Healthy Volunteers
Conditions: Rheumatic Diseases;   Healthy
Intervention:
2 Completed Women's Health Initiative (WHI)
Conditions: Bone Diseases;   Breast Neoplasms;   Cardiovascular Diseases;   Colonic Neoplasms;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia;   Osteoporosis;   Postmenopause
Interventions: Drug: hormone replacement therapy;   Drug: estrogens;   Drug: progestins;   Drug: estrogen replacement therapy;   Behavioral: diet, fat-restricted;   Drug: calcium;   Drug: vitamin D;   Behavioral: dietary supplements
3 Recruiting National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Conditions: Marfan Syndrome;   Turner Syndrome;   Ehlers-Danlos Syndrome;   Loeys-Dietz Syndrome;   FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation;   Bicuspid Aortic Valve Without Known Family History;   Bicuspid Aortic Valve With Family History;   Bicuspid Aortic Valve With Coarctation;   Familial Thoracic Aortic Aneurysm and Dissections;   Shprintzen-Goldberg Syndrome;   Other Aneurysms and Dissections of the Thoracic Aorta Not Due to Trauma, <50yo;   Other Congenital Heart Disease
Intervention:
4 Active, not recruiting Osteoarthritis Initiative (OAI): A Knee Health Study
Conditions: Osteoarthritis;   Knee Osteoarthritis
Intervention:
5 Completed Humanized LL2IGG to Treat Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: hLL2 (Epratuzumab)
6 Completed Study of Psoriatic Arthritis
Conditions: Psoriasis;   Psoriatic Arthritis
Intervention:
7 Completed Methimazole to Treat Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: methimazole
8 Completed A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis
Conditions: Arthritis, Psoriatic;   Psoriasis
Intervention: Drug: fludarabine
9 Completed Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
10 Completed Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity
Conditions: Lupus Erythematosus;   Systemic
Intervention: Drug: 2-deoxy-2 [F-18] fluoro-2-d-glucose
11 Completed Study of Silicone-Associated Connective Tissue Diseases
Conditions: Autoimmune Diseases;   Connective Tissue Diseases;   Scleroderma, Circumscribed;   Scleroderma, Systemic
Intervention:
12 Completed Genetic and Family Studies of Inherited Muscle Diseases
Conditions: Dermatomyositis;   Glycogen Storage Disease Type II;   Glycogen Storage Disease Type VII;   Myositis;   Polymyositis
Intervention:
13 Terminated Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Intervention: Drug: Infliximab
14 Completed The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept
Conditions: Rheumatoid Arthritis;   Healthy
Intervention: Drug: Etanercept
15 Completed Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine
Condition: Rheumatoid Arthritis
Intervention: Drug: TwHF
16 Completed Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis
Condition: Dermatomyositis
Intervention: Drug: h5G1.1-mAb
17 Completed The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis
Conditions: Arthritis;   Arthritis, Reactive;   Arthritis, Rheumatoid;   Reiter's Disease;   Synovitis
Intervention:
18 Completed Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status
Conditions: Arthritis, Rheumatoid;   Healthy;   Pregnancy
Intervention:
19 Completed Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
Conditions: Glomerulonephritis;   Lupus Nephritis;   Systemic Lupus Erythematosus
Intervention: Drug: SQ Fludarabine
20 Completed Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy
Conditions: Arthritis, Rheumatoid;   Synovitis
Interventions: Drug: Methotrexate;   Drug: Fludarabine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years